FY2025 Annual Report

Reporting period: 2025.01.01-2025.12.31

Summary: MP CARDIOFLOW-B (02160) reported Revenue of 400.95M(+9.79%); Operating profit of -91.33M(-44.38%); Net profit attributable to owners of -132.27M(-164.84%).

ReportedYoY
Prior YearYoY
RevenueUp YoY
400.95M9.79%
365.21M8.62%
Operating profitDown YoY
-91.33M44.38%
-63.26M79.83%
Net profit attributable to ownersDown YoY
-132.27M164.84%
-49.95M89.41%

Revenue

ReportedUnit: CNY

Operating profit

ReportedUnit: CNY

Net profit attributable to owners

ReportedUnit: CNY

Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.

About this page

This page shows MP CARDIOFLOW-B (02160) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect